2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with thromboxane b2 in 1 studies
| Studies (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Trials (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Recent Studies (post-2010) (2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 63 | 0 | 0 | 7,483 | 715 | 485 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R | 1 |
1 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and thromboxane b2
| Article | Year |
|---|---|
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha | 1991 |